Ensign Group (ENSG): are the analysts right?

Ensign Group · Health Care · ref. ETF XLV · 52 calls · price $160.13
What the company does: The Ensign Group Inc. fournit des services de soins infirmiers spécialisés, de vie senior et de réadaptation.
📈 1-year price
$170.87+17.2% over range
Jul 8, 25low $136.36 · high $215.83Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
50% recommend buying · 2 analysts

🎯 Analyst price target on ENSG

High target · 1 analyst$222+38.6%
Median target · 2 analysts$218.5+36.5%
Low target · 1 analyst$215+34.3%
Current price$160.13

🗳️ The analyst consensus

Analyst breakdown · 2 (6 months)
Strong Buy0%
Buy50%
Hold50%
Sell0%
Strong Sell0%

💰 Ensign Group dividend

0.16%annual yield
📈 Steady dividend18 yrs of consecutive dividend increases
That's ~$0.26 per share per year.

✅ Historical analyst reliability on ENSG

Most reliable analysts on ENSG (% profitable · 365j · ≥2 calls)
Macquarie 100% +31.8% 3
Stephens & Co. 100% +31.5% 10
Oppenheimer 100% +19.6% 7
RBC Capital 90% +17.3% 10

📊 What $1,000 invested in Ensign Group would be worth

In short — $1,000 invested in Ensign Group 10 years ago would be worth $7,572 today, i.e. +22%/yr on average. Best year: 2018 (+75%), worst: 2016 (-2%). Price performance, excluding dividends.

If I'd invested $1,000 in Ensign Group

InvestmentWorth todayGain
1 years ago$1,207+21%
3 years ago$1,694+69%
5 years ago$2,198+120%
10 years ago$7,572+657%
since inception (2007)$43,626+4263%

Return by year (Ensign Group)

YearReturn$1,000 invested at year start
2026 (YTD)-8%$920 (-8%)
2025+31%$1,207 (+21%)
2024+18%$1,429 (+43%)
2023+19%$1,694 (+69%)
2022+13%$1,909 (+91%)
2021+15%$2,198 (+120%)
2020+61%$3,533 (+253%)
2019+25%$4,418 (+342%)
2018+75%$7,719 (+672%)
20170%$7,715 (+672%)
2016-2%$7,572 (+657%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on ENSG

RBC Capital
Feb 9, 26
▲ Outperform · 🎯$222
Price at call : $203.93 — upside +9%
Today : $160.13 — upside +39%
🎯 on ENSG : 90% (10 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Feb 9, 27
■ Hold neutral · not a buy · 🎯$215
Price at call : $199.29 — gap to target +8%
Today : $160.13 — gap to target +34%
🎯 on ENSG : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Feb 6, 27
RBC Capital
Nov 14, 25
▲ Outperform · 🎯$206
Price at call : $177.56 — upside +16%
Today : $160.13 — upside +29%
🎯 on ENSG : 90% (10 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Nov 14, 26
■ Hold neutral · not a buy · 🎯$200
Price at call : $179.8 — gap to target +11%
Today : $160.13 — gap to target +25%
🎯 on ENSG : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Nov 10, 26
UBS
Nov 6, 25
▲ Buy · 🎯$220
Price at call : $182.91 — upside +20%
Today : $160.13 — upside +37%
🎯 on ENSG : 100% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Nov 6, 26
▲ Overweight · 🎯$200
Price at call : $182.91 — upside +9%
Today : $160.13 — upside +25%
🎯 on ENSG : 100% (10 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
in progress (365j)
matures : Nov 5, 26
UBS
Sep 2, 25
▲ Buy · 🎯$205
Price at call : $171.65 — upside +19%
Today : $160.13 — upside +28%
🎯 on ENSG : 100% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Sep 2, 26
UBS
Aug 14, 25
▲ Buy · 🎯$195
Price at call : $166.17 — upside +17%
Today : $160.13 — upside +22%
🎯 on ENSG : 100% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Aug 14, 26
■ Hold neutral · not a buy · 🎯$165
Price at call : $151.01 — gap to target +9%
Today : $160.13 — gap to target +3%
🎯 on ENSG : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Jul 28, 26
▲ Overweight · 🎯$170
Price at call : $147.78 — upside +15%
Today : $160.13 — upside +6%
🎯 on ENSG : 100% (10 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
in progress (365j)
matures : Jul 28, 26
Macquarie
May 2, 25
▲ Outperform · 🎯$156
Price at call : $131.78 — upside +18%
Today : $160.13 — upside -3%
Expected +18% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (3 calls matureds) · 📊 on Health : 80% · +19.0% (5 calls)
+38.1%
stock +38% · XLV +5%
▲ Overweight · 🎯$160
Price at call : $129.23 — upside +24%
Today : $160.13 — upside -0%
Expected +24% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (10 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
+54.2%
stock +54% · XLV +7%
▲ Overweight · 🎯$155
Price at call : $131 — upside +18%
Today : $160.13 — upside -3%
Expected +18% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (10 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
+52.1%
stock +52% · XLV +7%
Macquarie
Feb 4, 25
▲ Outperform · 🎯$166
Price at call : $148.86 — upside +12%
Today : $160.13 — upside +4%
Expected +12% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (3 calls matureds) · 📊 on Health : 80% · +19.0% (5 calls)
+32.5%
stock +32% · XLV +4%
■ Hold neutral · not a buy · 🎯$155
Price at call : $130.06 — gap to target +19%
Today : $160.13 — gap to target -3%
🎯 on ENSG : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Jan 6, 26
UBS
Nov 21, 24
▲ Buy · 🎯$175
Price at call : $147.35 — upside +19%
Today : $160.13 — upside +9%
Expected +19% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
+25.5%
stock +26% · XLV +7%
RBC Capital
Oct 28, 24
▲ Outperform · 🎯$172
Price at call : $156.91 — upside +10%
Today : $160.13 — upside +7%
Expected +10% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 90% (10 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+16.4%
stock +16% · XLV -3%
▲ Overweight · 🎯$167
Price at call : $156.91 — upside +6%
Today : $160.13 — upside +4%
Expected +6% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (10 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
+16.4%
stock +16% · XLV -3%
■ Hold neutral · not a buy · 🎯$170
Price at call : $156.91 — gap to target +8%
Today : $160.13 — gap to target +6%
🎯 on ENSG : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Oct 28, 25
Oppenheimer
Oct 25, 24
▲ Outperform · 🎯$168
Price at call : $151.87 — upside +11%
Today : $160.13 — upside +5%
Expected +11% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+22.8%
stock +23% · XLV -2%
RBC Capital
Oct 21, 24
▲ Outperform · 🎯$167
Price at call : $148.79 — upside +12%
Today : $160.13 — upside +4%
Expected +12% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 90% (10 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+24.2%
stock +24% · XLV -3%
Oppenheimer
Sep 16, 24
▲ Outperform · 🎯$165
Price at call : $153.67 — upside +7%
Today : $160.13 — upside +3%
Expected +7% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+6.9%
stock +7% · XLV -13%
■ Hold neutral · not a buy · 🎯$160
Price at call : $139.54 — gap to target +15%
Today : $160.13 — gap to target -0%
🎯 on ENSG : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Jul 31, 25
■ Hold neutral · not a buy · 🎯$150
Price at call : $139.86 — gap to target +7%
Today : $160.13 — gap to target -6%
🎯 on ENSG : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Jul 15, 25
Macquarie
Jun 28, 24
▲ Outperform · 🎯$134
Price at call : $123.69 — upside +8%
Today : $160.13 — upside -16%
Expected +8% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (3 calls matureds) · 📊 on Health : 80% · +19.0% (5 calls)
+24.7%
stock +25% · XLV -8%
Oppenheimer
May 6, 24
▲ Outperform · 🎯$135
Price at call : $116.05 — upside +16%
Today : $160.13 — upside -16%
Expected +16% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+15.1%
stock +15% · XLV -5%
▲ Overweight · 🎯$135
Price at call : $118.64 — upside +14%
Today : $160.13 — upside -16%
Expected +14% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 100% (10 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
+5.3%
stock +5% · XLV -2%
RBC Capital
Feb 6, 24
▲ Outperform · 🎯$133
Price at call : $117.39 — upside +13%
Today : $160.13 — upside -17%
Expected +13% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 90% (10 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+15.8%
stock +16% · XLV +2%
Oppenheimer
Feb 2, 24
▲ Outperform · 🎯$130
Price at call : $117.97 — upside +10%
Today : $160.13 — upside -19%
Expected +10% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+20.7%
stock +21% · XLV +4%
Oppenheimer
Jan 17, 24
▲ Outperform · 🎯$127
Price at call : $116 — upside +9%
Today : $160.13 — upside -21%
Expected +9% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+17.9%
stock +18% · XLV +1%
▲ Overweight · 🎯$113
Price at call : $95.32 — upside +19%
Today : $160.13 — upside -29%
Expected +19% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (10 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
+59.3%
stock +59% · XLV +20%
Berenberg
Sep 28, 23
▲ Buy · 🎯$110
Price at call : $93.97 — upside +17%
Today : $160.13 — upside -31%
Expected +17% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (1 call matured) · 📊 unranked overall
+53.4%
stock +53% · XLV +18%
■ Hold neutral · not a buy · 🎯$110
Price at call : $93.28 — gap to target +18%
Today : $160.13 — gap to target -31%
🎯 on ENSG : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Sep 12, 24
■ Hold neutral · not a buy · 🎯$110
Price at call : $95.41 — gap to target +15%
Today : $160.13 — gap to target -31%
🎯 on ENSG : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Sep 4, 24
▲ Overweight · 🎯$110
Price at call : $97.91 — upside +12%
Today : $160.13 — upside -31%
Expected +12% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (10 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
+43.2%
stock +43% · XLV +12%
RBC Capital
Jul 31, 23
▲ Outperform · 🎯$114
Price at call : $94.7 — upside +20%
Today : $160.13 — upside -29%
Expected +20% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 90% (10 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+48.6%
stock +49% · XLV +12%
RBC Capital
May 1, 23
▲ Outperform · 🎯$108
Price at call : $97.25 — upside +11%
Today : $160.13 — upside -33%
Expected +11% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 90% (10 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+21.7%
stock +22% · XLV +5%
▲ Overweight · 🎯$112
Price at call : $97.09 — upside +15%
Today : $160.13 — upside -30%
Expected +15% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (10 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
+22.3%
stock +22% · XLV +5%
■ Hold neutral · not a buy · 🎯$110
Price at call : $98.4 — gap to target +12%
Today : $160.13 — gap to target -31%
🎯 on ENSG : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Apr 12, 24
Oppenheimer
Feb 3, 23
▲ Outperform · 🎯$115
Price at call : $92.4 — upside +24%
Today : $160.13 — upside -28%
Expected +24% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+27.7%
stock +28% · XLV +7%
Oppenheimer
Jan 19, 23
▲ Outperform · 🎯$110
Price at call : $93.16 — upside +18%
Today : $160.13 — upside -31%
Expected +18% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+26.1%
stock +26% · XLV +5%
RBC Capital
Nov 1, 22
▲ Outperform · 🎯$102
Price at call : $91.69 — upside +11%
Today : $160.13 — upside -36%
Expected +11% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 90% (10 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+5.3%
stock +5% · XLV -6%
▲ Overweight · 🎯$101
Price at call : $89.78 — upside +12%
Today : $160.13 — upside -37%
Expected +12% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 100% (10 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
+6.2%
stock +6% · XLV -7%
Stifel
Sep 15, 22
▲ Buy · 🎯$105
Price at call : $84.95 — upside +24%
Today : $160.13 — upside -34%
Expected +24% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 100% (1 call matured) · 📊 on Health : 47.2% · +12.4% (89 calls)
+9.4%
stock +9% · XLV +3%
RBC Capital
Aug 3, 22
▲ Outperform · 🎯$95
Price at call : $83.87 — upside +13%
Today : $160.13 — upside -41%
Expected +13% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 90% (10 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+15.6%
stock +16% · XLV +1%
■ Hold neutral · not a buy · 🎯$85
Price at call : $73.63 — gap to target +15%
Today : $160.13 — gap to target -47%
🎯 on ENSG : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Jul 14, 23
RBC Capital
May 3, 22
▲ Outperform · 🎯$101
Price at call : $78.4 — upside +29%
Today : $160.13 — upside -37%
Expected +29% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 90% (10 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+19.6%
stock +20% · XLV +3%
RBC Capital
Oct 29, 21
▲ Outperform · 🎯$96
Price at call : $78.28 — upside +23%
Today : $160.13 — upside -40%
Expected +23% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 90% (10 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+14.7%
stock +15% · XLV -1%
■ Hold neutral · not a buy · 🎯$80
Price at call : $72.73 — gap to target +10%
Today : $160.13 — gap to target -50%
🎯 on ENSG : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Oct 13, 22
RBC Capital
May 3, 21
▲ Outperform · 🎯$100
Price at call : $86.54 — upside +16%
Today : $160.13 — upside -38%
Expected +16% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 90% (10 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-8.8%
stock -9% · XLV +8%
▲ Overweight · 🎯$79
Price at call : $64.3 — upside +23%
Today : $160.13 — upside -51%
Expected +23% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (10 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
+27.8%
stock +28% · XLV +21%
▲ Overweight · 🎯$39
Price at call : $8.26 — upside +372%
Today : $160.13 — upside -76%
Expected +372% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (10 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
+28.1%
stock +28% · XLV +32%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)